Search Results - "Meurer, Roger D."
-
1
Spiroimidazolidinone NPC1L1 inhibitors. Part 2: Structure–activity studies and in vivo efficacy
Published in Bioorganic & medicinal chemistry letters (01-12-2010)“…Ezetimibe (Zetia®), a cholesterol-absorption inhibitor (CAI) approved by the FDA for the treatment of hypercholesterolemia, is believed to target the intestine…”
Get full text
Journal Article -
2
Reconstituted HDL elicits marked changes in plasma lipids following single-dose injection in C57Bl/6 mice
Published in Journal of cardiovascular pharmacology and therapeutics (01-09-2012)“…High-density lipoprotein (HDL)-targeting therapies, including reconstituted HDL (rHDL), are attractive agents for treating dyslipidemia and atherosclerosis, as…”
Get more information
Journal Article -
3
Spiroimidazolidinone NPC1L1 inhibitors. 1: Discovery by 3D-similarity-based virtual screening
Published in Bioorganic & medicinal chemistry letters (01-06-2009)“…A series of spiroimidazolidinone NPC1L1 inhibitors was discovered by virtual screening of the Merck corporate sample repository using 3D-similarity-based…”
Get full text
Journal Article -
4
A pharmacologic analysis of the action of platelet-activating factor in the induction of hindpaw edema in the rat
Published in Prostaglandins (01-08-1984)“…Platelet-activating factor (PAF), a phospholipid product of neutrophils, alveolar macrophages, monocytes, and platelets and an important mediator of…”
Get more information
Journal Article -
5
The effect of calcium antagonists on contractions of the sensitized and normal guinea pig ileum
Published in Prostaglandins (01-01-1983)“…The purpose of this study was to learn whether a number of Ca2+ antagonists were effective in reducing contractile responses of the isolated ileum of the…”
Get more information
Journal Article